Sopris Capital operates with a permanent, evergreen capital base that allows them to deploy patient capital without traditional 10-year fund constraints, enabling flexible check sizing and long holding periods while maintaining a concentrated focus on early-stage healthcare companies with line of sight to $1M+ ARR. The firm combines deep healthcare expertise with a multi-strategy platform structure spanning venture capital, private equity, and real estate under one umbrella, plus they run less typical cash-yielding programs like profit-sharing kiosk portfolios alongside classic venture equity.